[PERSON]
Nandini Piramal
Featured in 2 tracked stories · first seen
Situations
Piramal Pharma business expansion and growth
2 clusters · 7 sources · last updated
Latest: Piramal Pharma acquires controlling stake in Yapan Bio
Piramal Pharma Limited reported strong financial performance for the first quarter of fiscal year 2027, noting a 17% increase in revenue to ₹2,270 crore and a 72% rise in EBITDA to ₹285 crore. Chairperson Nandini Piramal
Also covered in
-
Piramal Pharma releases 2025–26 Sustainability Report
[BUSINESS] · 2 sources ·